The Hopkins Lupus Pregnancy Center: ten key issues in management.
There is no consensus on the management of systemic lupus erythematosus (SLE), much less pregnancy in SLE patients. However, several key issues in the management of SLE in pregnancy are commonly faced by rheumatologists, nephrologists, and obstetricians. These include the treatment of SLE activity in pregnancy, the ascertainment of lupus nephritis, treatment of antiphospholipid antibodies, treatment of hypertension, and laboratory monitoring. These key issues will be examined in this chapter.
Petri
Michelle
M
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. mpetri@jhmi.edu
D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000032:analysis; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000628:therapy*; D008181:Lupus Nephritis / Q000453:epidemiology / Q000628:therapy; D011225:Pre-Eclampsia / Q000453:epidemiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology / Q000628:therapy*; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000453:epidemiology
D017152:Antibodies, Antiphospholipid